2684例甲状腺乳头状癌临床病理特征8年间变化分析

赵荧; 曹培龙; 赵华; 齐欣; 张冠军; 邓元; 蒋依娜; 牛蔓; 王鸿雁

doi:10.13201/j.issn.1001-1781.2019.04.020

2684例甲状腺乳头状癌临床病理特征8年间变化分析

- 1 西安交通大学第一附属医院病理科(西安, 710061);
- 2 兵器工业卫生研究所;
- 3 西安交通大学医学部公共卫生学院;
- 4 西安市第四医院病理科

详细信息

通讯作者: 王鸿雁,E-mail:whycc0320@126.com

中图分类号: R739.6

收稿日期: 2018-11-19

Clinical and pathologic analysis of 2 684 cases of papillary thyroid carcinoma in 8 years

- 1 Department of Pathology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China;
- 2 Institute of Ordnance Industry and Health;
- 3 School of Public Health, Xi'an Jiaotong University;
- 4 Department of Pathology, the Fourth Hospital of Xi'an

More Information

Corresponding author: WANG Hongyan, E-mail: whycc0320@126.com

Received Date: 19 November 2018

摘要

摘要: 目的:探讨甲状腺乳头状癌(PTC)患者的临床病理特征及年度特征。方法:回顾2010-2017年初次就诊于西安交通大学第一附属医院并行手术治疗的PTC患者的临床病理资料,描述分析其临床病理特征的年间变化。结果:8年间收集PTC患者共计2 684例,发病高峰年龄31~60岁,最高峰年龄41~55岁;男41~45岁,女46~50岁。8年间PTC患者的平均患病年龄差异无统计学意义(P>0.05)。总的男女比例在1.00:2.91波动(P>0.05)。男、女患者数量均呈上升趋势(P<0.05),增长近似平行。多灶性PTC及单灶性癌的比例近似平行(P>0.05)。PTC伴桥本甲状腺炎的比例呈现逐年上升趋势(P<0.05)。甲状腺微小乳头状癌中央区淋巴结转移率为15.81%,且其百分率8年间呈现逐年上升趋势(P<0.05)。结论:2010-2017年间PTC患者总数不断上升,平均患病年龄、性别比例差异无统计学意义,男、女患者数量增长近似平行。多灶性PTC及单灶性癌的比例近似平行。PTC伴桥本甲状腺炎的百分率呈逐年上升趋势,甲状腺微小乳头状癌的百分率呈现逐年上升趋势。
- 甲状腺乳头状癌 /
- 病理特征
Abstract: Objective: To study the clinicopathological and annual features of PTC patients in the past 8 years. Method: Review the clinicopathological data of PTC patients treated by surgery for the first time in the First Affiliated Hospital of Xi'an Jiaotong University from 2010 to 2017. Result: The total number of PTC patients was 2 684, which was increasing from 2010 to 2017. The peak age of onset of PTC was 31-60 years old, and the highest peak age was 41-55 years old, including 41-45 years for men and 46-50 years for women. There was no significant difference in the average age of PTC patients during the 8 years(P>0.05). The total male/female ratio oscillated between 1.00:2.91 and there was no significant difference(P>0.05). The increase in the number of male and female patients was approximately parallel. Both had an upward trend(P<0.05). The proportions of multifocal and single-tumor cancers were nearly parallel in the 8 years, and there was no significant difference(P>0.05). The percentage of PTC combined with HT increased year by year(P<0.05). The percentage of PTMC showed an increasing trend year by year(P<0.05). The rate of lymph node metastasis in the central area of PTMC was 15.81%.Conclusion: During the past 8 years, the growing number of PTC patients with different genders was approximately parallel. There was no significant difference in the average age and total male/female ratio of PTC patients. The proportions of multifocal and single-tumor cancers were nearly parallel. The percentage of PTC combined with HT has been increasing year by year. The percentage of PTMC showed an increasing trend.
- papillary thyroid carcinoma /
- clinical pathology

HTML全文

参考文献(15)

[1]	MD T R,MD H B,PERRIER N.The Updated AJCC/TNM Staging System for Differentiated and Anaplastic Thyroid Cancer(8th edition):What changed and why[J]?Thyroid Official J Am Thyroid Association,2017,27:751-756.
[2]	DAVIES L,WELCH H G.Current thyroid cancer trends in the United States[J].JAMA Otolaryngol Head Neck Surg,2014,140:317-322.
[3]	CHEN W,SUN K,ZHENG R,et al.Cancer incidence and mortality in China,2014[J].Chin J Cancer Res,2018,30:1-12.
[4]	DAVIES L,WELCH H G.Increasing incidence of thyroid cancer in the United States,1973-2002[J].JAMA,2006,295:2164-2167.
[5]	HODGSON N C,BUTTON J,SOLORZANO C C.Thyroid cancer:is the incidence still increasing[J]? Ann Surg Oncol,2004,11:1093-1097.
[6]	VERKOOIJEN H M,FIORETTA G,PACHE J C,et al.Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva,Switzerland[J].Cancer Causes Control,2003,14:13-17.
[7]	BONDESON L,LJUNGBERG O.Occult thyroid carcinoma at autopsy in Malmo,Sweden[J].Cancer,1981,47:319-323.
[8]	BURGESS J R,TUCKER P.Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology[J].Thyroid,2006,16:47-53.
[9]	MORRIS L G,SIKORA A G,MYSSIOREK D,et al.The basis of racial differences in the incidence of thyroid cancer[J].Ann Surg Oncol,2008,15:1169-1176.
[10]	MORRIS L G,MYSSIOREK D.Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer:a population-based analysis[J].Am J Surg,2010,200:454-461.
[11]	CHO S Y,LEE T H,KU Y H,et al.Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number,the size of metastatic foci,and the presence of desmoplasia[J].Surgery,2015,157:111-118.
[12]	ZHAO Q,MING J,LIU C,et al.Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma[J].Ann Surg Oncol,2013,20:746-752.
[13]	LIU X,ZHU L,WANG Z,et al.Evolutionary features of thyroid cancer in patients with thyroidectomies from 2008 to 2013 in China[J].Sci Rep,2016,6:28414.
[14]	KONTUREK A,BARCZYNSKI M,WIERZCHOWSKI W,et al.Coexistence of papillary thyroid cancer with Hashimoto thyroiditis[J].Langenbecks Arch Surg,2013,398:389-394.
[15]	LEE J H,KIM Y,CHOI J W,et al.The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis:a meta-analysis[J].Eur J Endocrinol,2013,168:343-349.